Literature DB >> 9657318

Evaluation of the antimicrobial effect of lactoferrin on Porphyromonas gingivalis, Prevotella intermedia and Prevotella nigrescens.

O Aguilera1, M T Andrés, J Heath, J F Fierro, C W Douglas.   

Abstract

The antimicrobial effect of lactoferrin (apoLf) on the oral, black-pigmented anaerobes Porphyromonas gingivalis, Prevotella intermedia and P. nitrescens has been studied. ApoLf did not kill any of these species but it did inhibit the growth of P. gingivalis, while iron-saturated Lf (FeLf) had no effect. The other two species were unaffected by apoLf. This growth inhibitory effect of apoLf could not be explained on the basis of chelation of inorganic iron, since growth of P. gingivalis occurred in the presence of ethylenediamine di-o-hydroxyphenylacetic acid provided haemin was added. Both apoLf and FeLf reduced haemin uptake by all three species and caused the release of cell-bound haemin in a dose-dependent manner. In addition, haemin reduced the binding of both apoLf and FeLf to P. intermedia and P. nigrescens but stimulated the binding of Lf by P. gingivalis. These data suggest that Lf forms complexes with haemin in solution and competes for the binding of haemin to certain cell receptors, possibly lipopolysaccharides, but this is not sufficient to inhibit growth of the bacteria. P. gingivalis appears to bind Lf-haemin complexes, as well as haemin alone, which may facilitate access of the Lf to the outer and cytoplasmic membranes of P. gingivalis, so disrupting function.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9657318     DOI: 10.1111/j.1574-695X.1998.tb01146.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  10 in total

1.  Effects of a composition containing lactoferrin and lactoperoxidase on oral malodor and salivary bacteria: a randomized, double-blind, crossover, placebo-controlled clinical trial.

Authors:  Kouichirou Shin; Ken Yaegaki; Takatoshi Murata; Hisataka Ii; Tomoko Tanaka; Izumi Aoyama; Koji Yamauchi; Tomohiro Toida; Keiji Iwatsuki
Journal:  Clin Oral Investig       Date:  2010-05-29       Impact factor: 3.573

2.  Regulation of fungal infection by a combination of amphotericin B and peptide 2, a lactoferrin peptide that activates neutrophils.

Authors:  Tetsuro Okamoto; Toyohiro Tanida; Benjuan Wei; Eisaku Ueta; Tetsuya Yamamoto; Tokio Osaki
Journal:  Clin Diagn Lab Immunol       Date:  2004-11

3.  Lactoferrin peptide increases the survival of Candida albicans-inoculated mice by upregulating neutrophil and macrophage functions, especially in combination with amphotericin B and granulocyte-macrophage colony-stimulating factor.

Authors:  T Tanida; F Rao; T Hamada; E Ueta; T Osaki
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

4.  Inhibitory effects of lactoferrin on growth and biofilm formation of Porphyromonas gingivalis and Prevotella intermedia.

Authors:  Hiroyuki Wakabayashi; Koji Yamauchi; Tetsuo Kobayashi; Tomoko Yaeshima; Keiji Iwatsuki; Hiromasa Yoshie
Journal:  Antimicrob Agents Chemother       Date:  2009-05-18       Impact factor: 5.191

5.  Effects of orally administered lactoferrin and lactoperoxidase-containing tablets on clinical and bacteriological profiles in chronic periodontitis patients.

Authors:  Eiju Shimizu; Tetsuo Kobayashi; Hiroyuki Wakabayashi; Koji Yamauchi; Keiji Iwatsuki; Hiromasa Yoshie
Journal:  Int J Dent       Date:  2011-04-03

6.  Assessment of peritoneal microbial features and tumor marker levels as potential diagnostic tools for ovarian cancer.

Authors:  Ruizhong Miao; Taylor C Badger; Kathleen Groesch; Paula L Diaz-Sylvester; Teresa Wilson; Allen Ghareeb; Jongjin Anne Martin; Melissa Cregger; Michael Welge; Colleen Bushell; Loretta Auvil; Ruoqing Zhu; Laurent Brard; Andrea Braundmeier-Fleming
Journal:  PLoS One       Date:  2020-01-09       Impact factor: 3.240

7.  A randomized, double-blind, crossover, placebo-controlled clinical trial to assess effects of the single ingestion of a tablet containing lactoferrin, lactoperoxidase, and glucose oxidase on oral malodor.

Authors:  Manabu Nakano; Eiju Shimizu; Hiroyuki Wakabayashi; Koji Yamauchi; Fumiaki Abe
Journal:  BMC Oral Health       Date:  2016-03-22       Impact factor: 2.757

Review 8.  Oral antimicrobial peptides: Types and role in the oral cavity.

Authors:  Zohaib Khurshid; Mustafa Naseem; Zeeshan Sheikh; Shariq Najeeb; Sana Shahab; Muhammad Sohail Zafar
Journal:  Saudi Pharm J       Date:  2015-03-06       Impact factor: 4.330

9.  Effects of orally administered lactoferrin and lactoperoxidase on symptoms of the common cold.

Authors:  Kouichirou Shin; Hiroyuki Wakabayashi; Chihiro Sugita; Hiroki Yoshida; Keizo Sato; Tohru Sonoda; Koji Yamauchi; Fumiaki Abe; Masahiko Kurokawa
Journal:  Int J Health Sci (Qassim)       Date:  2018 Sep-Oct

10.  The combination of lactoferrin and linolenic acid inhibits colorectal tumor growth through activating AMPK/JNK-related apoptosis pathway.

Authors:  Qianqian Yao; Huiying Li; Linlin Fan; Shengnan Huang; Jiaqi Wang; Nan Zheng
Journal:  PeerJ       Date:  2021-05-31       Impact factor: 2.984

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.